Actinium Pharmaceuticals (ATNM) Q2 2024 Earnings

26AprConfirmed
Q1 2023
Q2 2023
Q3 2023
Q2 2024
-0.51
-0.34
-0.17
0

Details

Expected EPS
-0.378
Actual EPS
-0.31
Surprise EPS
0.07
Surprise Percent
+17.99%

Description

Actinium Pharmaceuticals (ATNM) has reported earnings of -0.31 per share for Q2 2024.

0 Comments

Share your thoughts